Daniel Liebler Archives
Team’s discovery offers new insight on lung cancer risk
Jan. 12, 2017—Researchers in the Schools of Medicine and Engineering at Vanderbilt University have discovered a proteomic “signature” from the airways of heavy smokers that could lead to better risk assessment and perhaps new ways to stop lung cancer before it starts.
Ayers Institute spurred key cancer research gains
Nov. 12, 2015—In 2005, Tennessee philanthropists Jim and Janet Ayers gave $10 million to help Vanderbilt University scientists find early markers for colorectal cancer that could improve diagnosis and potentially save lives.
Study sheds light on a ‘guardian’ protein of brain function
Feb. 19, 2015—Mitochondria not only are the cell’s main power producers, they are also the chief cooks and bottle washers.
VU study creates new road map for cellular activity
Sep. 4, 2014—Human cells are constructed in large part from proteins whose activity can be altered by the incorporation of oxygen in what are known as redox modifications.
Colon cancer’s protein signatures identified
Jul. 24, 2014—A Vanderbilt University-led research team has identified protein “signatures” of genetic mutations that drive colorectal cancer, the nation’s second leading cause of cancer deaths after lung cancer.
American Chemical Society honors VUMC’s Liebler
Aug. 15, 2013—Daniel Liebler, Ph.D., Ingram Professor of Cancer Research, professor of Biochemistry, and director of the Ayers Institute for Precancer Detection and Diagnosis, has been selected as one of 96 fellows of the American Chemical Society (ACS), the world’s largest scientific society.
Cancer markers from archived tissue
Dec. 20, 2012—Archived tissue samples are yielding new disease biomarkers.
